申请人:Japan Tobacco Inc.
公开号:EP3456713A1
公开(公告)日:2019-03-20
Provided is a process for the production of a compound represented by the formula [I] or a pharmaceutically acceptable salt thereof:
wherein each symbol is as defined in the specification. Said compound has an mPGES-1 inhibitory activity and is useful for the prophylaxis or treatment of pain, rheumatism, osteoarthritis, fever, Alzheimer's disease, multiple sclerosis, arteriosclerosis, glaucoma, ocular hypertension, ischemic retinal disease, systemic scleroderma and cancer including colorectal cancer.
本发明提供了一种生产式 [I] 所代表的化合物或其药学上可接受的盐的工艺:
其中各符号如说明书中所定义。所述化合物具有 mPGES-1 抑制活性,可用于预防或治疗疼痛、风湿病、骨关节炎、发热、老年痴呆症、多发性硬化症、动脉硬化、青光眼、眼压过高、缺血性视网膜疾病、系统性硬皮病和癌症(包括结直肠癌)。